# Aβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease

> **NCT07114224** · NA · NOT_YET_RECRUITING · sponsor: **Xijing Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Alzheimer Disease (AD)
- Cognitive Dysfunction, Cognitive Disorder
- PET Imaging

## Interventions

- **DIAGNOSTIC_TEST:** AV45/AV-1、AV1451 PET

## Key facts

- **NCT ID:** NCT07114224
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-15
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07114224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07114224, "Aβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT07114224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*